Literature DB >> 10079383

Human herpesvirus 8 in hematologic diseases.

G Mikala1, J Xie, G Berencsi, C Kiss, I Márton, G Domján, I Vályi-Nagy.   

Abstract

Human herpesvirus type 8 (HHV-8), also known as Kaposi's sarcoma-associated herpesvirus (KSHV) is a new member of the g-herpesvirus family. It is an unusual herpesvirus in that it carries a large number of genes that encode oncoproteins or cell signaling proteins. In addition to being the causative agent of both HIV-associated and non-HIV-associated Kaposi's sarcoma this DNA tumor virus has been implicated in the pathogenesis of several diseases. These include multiple myeloma (MM), Waldenstöm's macroglobulinemia (WM), multicentric Castleman's disease (MCD), body cavity-based lymphoma (BCBL), and various other conditions such as sarcoidosis and pemphigus. While the causative role of the viral infection is fairly certain in the development of BCBL and multicentric Castleman's disease, HHV-8 may act through a different mechanism to induce plasma cell malignancies. It has been suggested though the finding is still controversial - that infection of bone marrow stromal dendritic cells by HHV-8 might be a key factor in the etiology and pathogenesis of monoclonal gammopathies. The aim of this review is to provide a short introduction into the tumorigenic potential of HHV-8 as well as to detail the available data and possible mechanisms on the involvement of this virus in different hematologic diseases.

Entities:  

Mesh:

Year:  1999        PMID: 10079383     DOI: 10.1053/paor.1999.0073

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  37 in total

1.  Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus.

Authors:  R G Nador; E Cesarman; A Chadburn; D B Dawson; M Q Ansari; J Sald; D M Knowles
Journal:  Blood       Date:  1996-07-15       Impact factor: 22.113

2.  Detection of human herpesvirus-8 DNA in bone marrow biopsies from patients with multiple myeloma and Waldenström's macroglobulinemia.

Authors:  F Agbalika; X Mariette; J P Marolleau; J P Fermand; J C Brouet
Journal:  Blood       Date:  1998-06-01       Impact factor: 22.113

3.  Causing cancer by remote control?

Authors:  T Gura
Journal:  Science       Date:  1997-06-20       Impact factor: 47.728

4.  Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene.

Authors:  S Muralidhar; A M Pumfery; M Hassani; M R Sadaie; M Kishishita; J N Brady; J Doniger; P Medveczky; L J Rosenthal
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma.

Authors:  J W Said; M R Rettig; K Heppner; R A Vescio; G Schiller; H J Ma; D Belson; A Savage; I P Shintaku; H P Koeffler; H Asou; G Pinkus; J Pinkus; M Schrage; E Green; J R Berenson
Journal:  Blood       Date:  1997-12-01       Impact factor: 22.113

6.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

7.  Human herpesvirus 8 variants in sarcoid tissues.

Authors:  L Di Alberti; A Piattelli; L Artese; G Favia; S Patel; N Saunders; S R Porter; C M Scully; S L Ngui; C G Teo
Journal:  Lancet       Date:  1997-12-06       Impact factor: 79.321

8.  Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus.

Authors:  H Lee; R Veazey; K Williams; M Li; J Guo; F Neipel; B Fleckenstein; A Lackner; R C Desrosiers; J U Jung
Journal:  Nat Med       Date:  1998-04       Impact factor: 53.440

9.  Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells.

Authors:  H Asou; J W Said; R Yang; R Munker; D J Park; N Kamada; H P Koeffler
Journal:  Blood       Date:  1998-04-01       Impact factor: 22.113

10.  Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.

Authors:  E T Lennette; D J Blackbourn; J A Levy
Journal:  Lancet       Date:  1996-09-28       Impact factor: 79.321

View more
  2 in total

1.  Differential regulation of umbilical cord blood and leukemic B cells by interferon-alpha (IFN-alpha): observations in cultured cells.

Authors:  István Szegedi; Csongor Kiss; Eva Karászi; György Vámosi; János Szöllôsi; Péter Kovács; Ilona Benkô
Journal:  Pathol Oncol Res       Date:  2006-09-23       Impact factor: 3.201

2.  Risk of malignant lymphoma associated with human herpesvirus-8: a case-control study in Spain.

Authors:  S de Sanjosé; J J Goedert; V Marshall; C Bellas; Y Benavente; R Bosch; A Domingo; A Fernandez de Sevilla; O Servitje; D Whitby
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.